Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

NCT02462486 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

949

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Degeneration

Interventions

DRUG: Abicipar Pegol
DRUG: Ranibizumab
OTHER: Sham Procedure

Sponsor

Allergan